Immediate Impact
55 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
2024 Standout
Works of Anthony Louder being referenced
Factors Associated with Adherence to and Treatment Duration of Erlotinib Among Patients with Non-Small Cell Lung Cancer
2017
Farydak (Panobinostat): First HDAC Inhibitor Approved for Patients with Relapsed Multiple Myeloma.
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Anthony Louder | 42 | 69 | 37 | 69 | 68 | 17 | 345 | |
| Julie Couture | 44 | 49 | 27 | 98 | 67 | 19 | 367 | |
| Przemysław Holko | 22 | 46 | 33 | 50 | 37 | 32 | 348 | |
| Chun‐Lan Chang | 31 | 47 | 52 | 65 | 109 | 27 | 392 | |
| Sruthi Adimadhyam | 13 | 26 | 26 | 56 | 47 | 21 | 327 | |
| Farrah Pompilus | 35 | 38 | 29 | 92 | 21 | 23 | 341 | |
| M. Lebmeier | 76 | 81 | 46 | 18 | 80 | 21 | 395 | |
| Rajeshwari Punekar | 8 | 109 | 76 | 24 | 32 | 20 | 315 | |
| Brian Bekker Hansen | 7 | 26 | 51 | 114 | 93 | 17 | 412 | |
| Ying Lu | 9 | 89 | 59 | 43 | 12 | 18 | 355 | |
| Steve Hughes | 8 | 33 | 59 | 156 | 30 | 17 | 357 |
All Works
Loading papers...